Drugs / autologous endothelial progenitor cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02605707 | Nov 2014 → Dec 2017 | ischemic stroke | Southern Medical University, China | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous endothelial progenitor cells | “The main objective of this study is to evaluate the efficacy and safy of the transplantation of autologous endothelial progenitor cells in patients with chronic stroke.” NCT02605707 ↗ |
| Route | Intravenous | “Intravenous injection of autologous endothelial progenitor cells transplantation” NCT02605707 ↗ |